Loading...

Nippon Shinyaku Co., Ltd.

NPPNYPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$8.15
$0.75(10.14%)
U.S. Market opens in 14h 14m

Nippon Shinyaku Co., Ltd. (NPPNY) Stock Overview

Explore Nippon Shinyaku Co., Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2B
P/E Ratio10.52
EPS (TTM)$0.75
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$9.50
3 Months$9.25
1 Year Target$8.75

NPPNY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Nippon Shinyaku Co., Ltd. (NPPNY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 29.47, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $8.75.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 10.52 and a market capitalization of 2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
10.14%
5-Day Change
10.14%
1-Month Change
-3.55%
3-Month Change
-9.44%
6-Month Change
53.20%
Year-to-Date (YTD) Change
-9.14%
1-Year Change
35.61%
3-Year Change
-27.88%
5-Year Change
-53.53%
All-Time (Max) Change
-35.32%

Contact Information

81 7 5321 1111
14, Nishinosho-Monguchi-cho, Kyoto, NaN, 601-8550

Company Facts

2,213 Employees
IPO DateNov 16, 2016
CountryJP
Actively Trading

Frequently Asked Questions